Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir, covering 2016-06-29 to 2016-06-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis [Phase 3]